Mark Bakken

Director at Cancer IQ.

Raised on Cancer IQ filings

$4.3M

of $6M offered across 1 Form D filing

Form D filings: 1
Teammates: 4
Last filing: May 26, 2026

Company

Healthcare · Chicago, IL

Hereditary cancer risk screening software for clinics

Hereditary cancer risk screening software for clinics

Investors: 9
Still open: $1.7M

Investors: 9
Sector: Healthcare
HQ: Chicago, IL

Cancer IQ filings

Cancer IQ Form D filings
Filed	Security	Sold of offered	Filing
May 26, 2026	Security to be acquired	$4.3M/ $6M	Form D/A

Security to be acquiredFiled May 26, 2026Form D/A
$4.3M/ $6M

Works with

Also named on Cancer IQ filings

Olufeyikemi Olopade AyodeleChief Executive Officer, Form D signerForm D signer Carladenise EdwardsDirector Haibo LuExecutive Officer, Director Joel KrikstonDirector